LEF1 and breast carcinoma: Recent studies revealed that LEF1 enhances the expression of two transcriptional ‘drivers’ of EMT [reviewed in (2)], ZEB2 and SNAI2 (SLUG), in breast carcinoma-derived MDA-MB-231 cells (44).